Adrian Dana

778 total citations
13 papers, 536 citations indexed

About

Adrian Dana is a scholar working on Epidemiology, Surgery and Pharmacology. According to data from OpenAlex, Adrian Dana has authored 13 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 4 papers in Surgery and 3 papers in Pharmacology. Recurrent topics in Adrian Dana's work include Cervical Cancer and HPV Research (5 papers), Genital Health and Disease (4 papers) and Antibiotic Use and Resistance (3 papers). Adrian Dana is often cited by papers focused on Cervical Cancer and HPV Research (5 papers), Genital Health and Disease (4 papers) and Antibiotic Use and Resistance (3 papers). Adrian Dana collaborates with scholars based in United States, Japan and Germany. Adrian Dana's co-authors include Joseph L. Kuti, David P. Nicolau, David F. Mercer, William K. Lau, Chonghua Li, Charles H. Nightingale, Kamal M.F. Itani, Richard M. Haupt, Michael L. Cunningham and Fabio Lievano and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Antimicrobial Agents and Chemotherapy and Obstetrics and Gynecology.

In The Last Decade

Adrian Dana

13 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adrian Dana United States 10 335 180 107 90 76 13 536
Endre Ludwig Hungary 11 243 0.7× 76 0.4× 24 0.2× 35 0.4× 58 0.8× 34 403
Chien‐Yu Cheng Taiwan 15 302 0.9× 137 0.8× 81 0.8× 173 1.9× 419 5.5× 56 835
Douwe F. Postma Netherlands 13 488 1.5× 55 0.3× 51 0.5× 31 0.3× 182 2.4× 37 733
L. Farbman Israel 10 133 0.4× 113 0.6× 18 0.2× 177 2.0× 63 0.8× 12 417
Laveta Stewart United States 11 206 0.6× 34 0.2× 120 1.1× 20 0.2× 61 0.8× 30 760
Yaakov Dickstein Israel 14 193 0.6× 104 0.6× 30 0.3× 155 1.7× 121 1.6× 24 622
Cumhur Y. Demirkale United States 10 174 0.5× 58 0.3× 44 0.4× 98 1.1× 84 1.1× 19 488
Judith A. O’Donnell United States 14 212 0.6× 64 0.4× 178 1.7× 25 0.3× 156 2.1× 29 562
Min Hyok Jeon South Korea 15 193 0.6× 71 0.4× 77 0.7× 151 1.7× 123 1.6× 47 504
Yu. V. Lobzin Russia 10 237 0.7× 23 0.1× 30 0.3× 90 1.0× 194 2.6× 99 593

Countries citing papers authored by Adrian Dana

Since Specialization
Citations

This map shows the geographic impact of Adrian Dana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Dana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Dana more than expected).

Fields of papers citing papers by Adrian Dana

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Dana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Dana. The network helps show where Adrian Dana may publish in the future.

Co-authorship network of co-authors of Adrian Dana

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Dana. A scholar is included among the top collaborators of Adrian Dana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Dana. Adrian Dana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Brown, Kari, James R. Baker, Andrea Vereda, et al.. (2021). Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials. Journal of Allergy and Clinical Immunology. 149(6). 2043–2052.e9. 15 indexed citations
2.
Lievano, Fabio, et al.. (2015). Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine. Vaccine. 33(29). 3422–3428. 40 indexed citations
3.
Marin, Mona, et al.. (2014). 1048Pregnancy Registry for Varicella-Zoster Virus-Containing Vaccines: 18-Year Summary of Pregnancy Outcomes. Open Forum Infectious Diseases. 1(suppl_1). S307–S307. 3 indexed citations
4.
Marin, Mona, et al.. (2014). Closure of varicella-zoster virus-containing vaccines pregnancy registry - United States, 2013.. PubMed. 63(33). 732–3. 12 indexed citations
5.
Lievano, Fabio, et al.. (2014). No Adverse Signals Observed After Exposure to Human Papillomavirus Type 6/11/16/18 Vaccine During Pregnancy. Obstetrics and Gynecology. 123(Supplement 1). 93S–93S. 8 indexed citations
6.
Lievano, Fabio, Richard T. Wiedmann, Susan B. Manoff, et al.. (2012). Measles, mumps, and rubella virus vaccine (M–M–R™II): A review of 32 years of clinical and postmarketing experience. Vaccine. 30(48). 6918–6926. 62 indexed citations
7.
Block, Stan L., Darron R. Brown, Archana Chatterjee, et al.. (2010). Clinical Trial and Post-Licensure Safety Profile of a Prophylactic Human Papillomavirus (Types 6, 11, 16, and 18) L1 Virus-Like Particle Vaccine. The Pediatric Infectious Disease Journal. 29(2). 95–101. 84 indexed citations
8.
Dana, Adrian, et al.. (2010). Pregnancy Outcomes From the Pregnancy Registry of a Human Papillomavirus Type 6/11/16/18 Vaccine. Obstetrical & Gynecological Survey. 65(3). 169–170. 4 indexed citations
9.
Dana, Adrian, et al.. (2009). Pregnancy Outcomes From the Pregnancy Registry of a Human Papillomavirus Type6/11/16/18 Vaccine. Obstetrics and Gynecology. 114(6). 1170–1178. 56 indexed citations
10.
Lau, William K., David F. Mercer, Kamal M.F. Itani, et al.. (2006). Randomized, Open-Label, Comparative Study of Piperacillin-Tazobactam Administered by Continuous Infusion versus Intermittent Infusion for Treatment of Hospitalized Patients with Complicated Intra-Abdominal Infection. Antimicrobial Agents and Chemotherapy. 50(11). 3556–3561. 105 indexed citations
11.
DeRyke, C Andrew, et al.. (2006). Pharmacoeconomics of continuous versus intermittent infusion of piperacillin–tazobactam for the treatment of complicated intraabdominal infection. American Journal of Health-System Pharmacy. 63(8). 750–755. 12 indexed citations
12.
13.
Li, Chonghua, et al.. (2005). Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection. Journal of Antimicrobial Chemotherapy. 56(2). 388–395. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Endre Ludwig Breakdown of academic impact, for papers by Chien‐Yu Cheng Breakdown of academic impact, for papers by Douwe F. Postma Breakdown of academic impact, for papers by L. Farbman Breakdown of academic impact, for papers by Laveta Stewart Breakdown of academic impact, for papers by Yaakov Dickstein Breakdown of academic impact, for papers by Cumhur Y. Demirkale Breakdown of academic impact, for papers by Judith A. O’Donnell Breakdown of academic impact, for papers by Min Hyok Jeon Breakdown of academic impact, for papers by Yu. V. Lobzin
Rankless by CCL
2026